Neutrophils are important effector cells in the defense against microorganisms. They migrate into infected sites and then phagocytose and kill bacteria. Chemotactic factors may be important for initiating neutrophil migration. We investigated whether chemotactic factors might also influence an event subsequent to chemotaxis, namely bacterial killing. It was found that preincubation (20 min at 3700) of human leukocytes with chemotactic substances such as zymosan-activated serum, a C5a-containing fraction of zymosan-activated serum, N-formyl methionyl phenylalanine or N-formyl methionyl-leucine-phenylalanine, enhanced leukocyte killing of Staphylococcus aureus, Escherichia coli, and Streptococcus faecalis in a dose-dependent fashion. The concentration of chemotactic factor required to enhance killing was similar to that required to induce neutrophil chemotaxis. In addition, zymosan-activated serum, C5a fraction, and the two Nformyl methionyl peptides increased the hexose monophosphate shunt activity of resting and phagocytosing neutrophils by two-to threefold. In contrast, bacterial killing by sodium azide-treated neutrophils and neutrophils from a patient with chronic granulomatous disease was not increased by any chemotactic factor. These findings suggest that chemotactic factors stimulate neutrophil oxygendependent microbicidal pathways. These observations illustrate another important contribution of biologically active molecules to effector cell function and host defense.
Neutrophils are important effector cells in the defense against microorganisms. They migrate into infected sites and then phagocytose and kill bacteria. Chemotactic factors may be important for initiating neutrophil migration. We investigated whether chemotactic factors might also influence an event subsequent to chemotaxis, namely bacterial killing. It was found that preincubation (20 min at 3700) of human leukocytes with chemotactic substances such as zymosan-activated serum, a C5a-containing fraction of zymosan-activated serum, N-formyl methionyl phenylalanine or N-formyl methionyl-leucine-phenylalanine, enhanced leukocyte killing of Staphylococcus aureus, Escherichia coli, and Streptococcus faecalis in a dose-dependent fashion. The concentration of chemotactic factor required to enhance killing was similar to that required to induce neutrophil chemotaxis. In addition, zymosan-activated serum, C5a fraction, and the two Nformyl methionyl peptides increased the hexose monophosphate shunt activity of resting and phagocytosing neutrophils by two-to threefold. In contrast, bacterial killing by sodium azide-treated neutrophils and neutrophils from a patient with chronic granulomatous disease was not increased by any chemotactic factor. These findings suggest that chemotactic factors stimulate neutrophil oxygendependent microbicidal pathways. These observations illustrate another important contribution of biologically active molecules to effector cell function and host defense.
Chemotaxis of neutrophils into inflammatory sites is central to host defense against microorganisms. Neutrophils may migrate in response to a variety of chemotactic factors. The mechanism(s) by which these chemoattractants initiate neutrophil movement is not known. In addition to inducing neutrophil migration, chemotactic factors may modulate other neutrophil functions which could also be important in inflammation. For example, chemotactic factors stimulate extracellular lysosomal enzyme release (3, 10, 17) . Furthermore, neutrophil metabolism, for example, hexose monophosphate shunt (HMPS) activity (9) , superoxide production (11) , and cellular chemiluminescence (2, 12) In experiments employing autologous ZAS as the test substance, fresh autologous serum was the control substance. Leukocytes were incubated with ZAS or autologous serum for 20 min, washed once with HBSS, and resuspended in 0.4 ml of HBSS. The leukocytes were washed so that the final concentration of serum in the bactericidal assay could be standardized at 10%. The bacteria and serum were then added to this washed leukocyte suspension as described above.
At different time intervals (20, 90, and 180 min), 0.1 ml of the incubation mixtures were diluted in distilled water to lyse the leukocytes. The total viable bacteria (intracellular and extracellular) were determined by pour-plate colony counts. To quantitate the number of viable intracellular bacteria, penicillin and streptomycin (100 U/ml and 100 jug/ml, respectively) (GIBCO) were added to one of the duplicate tubes after 20 min of incubation as previously described (1). Only viable intracellular bacteria were quantitated after washing the leukocytes and then lysing them with distilled water. When sodium azide (Sigma)-treated leukocytes were examined, sodium azide was added to the leukocyte suspension at the start of the first incubation. Leukocytes from a patient with chronic granulomatous disease (CGD) were also examined. The patient was a male whose leukocytes had the characteristic metabolic and bactericidal abnormalities previously described for this disease (13) .
Enhanced bacterial killing by leukocytes was calculated according to the formula: percent increased killing = viable bacteria with control leukocytesviable bacteria with treated leukocytes/viable bacteria with control leukocytes x 100.
Results are expressed as a percent increase relative to control leukocytes examined in parallel. Although there was some day-to-day variation in the bactericidal capacity of control leukocytes, there was never any overlap between chemotactic factor-treated leukocytes and control leukocytes. Neutrophil viability was assessed by trypan blue dye (0.2%) (GIBCO) exclusion.
Bacteria. Staphylococcus aureus 502A, Escherichia coli, and Streptococcus faecalis were used.
Bacteria were grown in nutrient broth for 16 h before use. When preopsonized S. aureus was required, the pellet of bacteria from a 10-ml broth tube (16-h culture) was resuspended in 2 ml of a 1:2 dilution of fresh serum and incubated for 60 min at 370C. The opsonized bacteria were then washed with 10 volumes of HBSS.
HMPS activity. HMPS activity of leukocytes at rest and during phagocytosis was determined by measuring the quantity of '4CO2 generated from [1-'4C]-glucose as previously described (13) . Leukocytes were preincubated for 20 min at 370C with a test substance 
RESULTS
Effect of ZAS on leukocyte bactericidal activity. Figure 1 shows the results of a representative experiment designed to test the effect of ZAS on the phagocytosis and killing of bacteria by leukocytes. Leukocytes preincubated with 4.5% ZAS killed more S. aureus at 20, 90, and 180 min than control leukocytes preincubated with normal autologous serum (Fig. 1,  top) . When intracellular bacteria were quantitated in the tubes containing penicillin and streptomycin, leukocytes treated with ZAS contained fewer viable intracellular bacteria than control leukocytes. These findings indicate that the increased killing ofS. aureus by ZAS-treated leukocytes can not be explained by enhanced phagocytosis alone. In the bottom of Fig. 1 (Fig. 3) . Enhancement of bactericidal activity was maximal at a concentration In the absence of leukocytes, C5a had no effect on bacterial growth. In addition, when bacteria were preincubated with C5a for 20 min, washed, and then added to control leukocytes with serum at a final concentration of 10%, bacterial killing was not affected.
When increasing concentrations of the C5a fraction were tested for chemotactic activity, a concentration of 1.2 ,ug/ml elicited 25% (CD = (Fig. 4) . In the absence of leukocytes, FMP, FMLP, and LMP had no effect on bacterial growth. Furthermore, when bacteria were preincubated with these peptides and washed, the bacteria were killed normally by leukocytes.
The ability of chemotactic factors to increase leukocyte killing of different bacteria was examined. The C5a fraction at 1. (Fig. 5) . Similarly, ZAS (4.5%) increased the HMPS activity by 2.2-fold relative to control leukocytes treated with normal serum. When chemotactic factor-treated leukocytes were challenged with opsonized S. aureus (10 bacteria to 1 neutrophil), the HMPS activity was increased 1.6-to 2.4-fold over cells challenged with bacteria but not exposed to a chemotactic factor (Fig. 5) . At a bacteria-to-neutrophil ratio (100:1), which caused maximal stimulation of HMPS, no further increase in HMPS was observed when leukocytes were treated with a chemotactic factor. LMP (10-9 to 10-3 M) had no significant effect on the HMPS activity of resting leukocytes or leukocytes challenged with bacteria.
To determine whether chemotactic factors enhanced bactericidal pathways dependent or independent of oxidative metabolism, sodium azide-treated normal leukocytes and leukocytes from a patient with CGD were examined. Sodium azide (1 mM) markedly inhibited bacterial killing by normal leukocytes, although cell viability as judged by trypan blue dye exclusion, was not impaired (Fig. 6 ). When sodium azidetreated leukocytes were exposed to C5a, no increase in bacterial killing was observed. Similar results were observed with FMP (not shown). In addition, the abnormal killing of S. aureus by leukocytes from a patient with CGD was not influenced by C5a at several different concentrations (0.4, 1.2, and 3.6 ,ug of protein per ml) and on three separate occasions.
On two occasions CGD leukocytes killed S. faecalis normally, but killing of this bacterium could also not be enhanced by C5a or FMP (not shown). In contrast, C5a and FMP did enhance the killing of S. faecalis by normal leukocytes (45 ± 12% and 43 ± 10%, respectively, at 180 min).
Finally, neither C5a nor FMP stimulated the HMPS of CGD leukocytes (CGD -control, 180 cpm/2.5 X 106 PMN per 20 min; C5a treated, 165 cpm/2.5 x 106; FMP treated, 200 cpm/2.5 X 106). In contrast, CGD neutrophils migrated normally towards the two chemotactic factors (C5a-CGD, CD = 5; control = 6.0 ± 0.5; FMP-CGD, CD = 8; control CD = 9 ± 0.6 SEM). (Fig. 4) to the same extent as the C5a fraction and like C5a, at a concentration which was similar to that required to induce chemotaxis in the agarose assay. The finding that a 3-to 10-times higher concentration of factors was required to induce optimal chemotaxis than to optimally enhance bacterial killing may have been due to dilution of the chemotactic factors during diffusion in agarose. These observations suggest that the same molecule which induced neutrophil chemotaxis also enhanced bacterial killing. This conclusion is further supported by the finding that LMP, a peptide analog of FMP, which lacked chemotactic activity, had a negligible effect on the bactericidal activity of neu-1 I~t rophies (Fig. 4) . (18) found that even at bacteria-to-neutrophil cubation times is ratios of 10:1, 80% of the S. aureus was ingested within 20 min by control neutrophils. Second, the chemotactic factors may have stimulated re generated by the initial rate of phagocytosis. Our results do trated that ZAS, not exclude this possibility. However, it is unh was chemotac-likely that a stimulatory effect limited to this ureus by neutro-early event would result in enhanced bacterial effect was ob-killing which persisted for 3 h. Furthermore, if neutrophil ratios. the chemotactic factors primarily acted to iniltration (Fig. 2) crease the rate or extent of phagocytosis, then ;actic and bacte-the number ofviable intracellular bacteria would ;AS were present have been greater in chemotactic factor-treated nd therefore ap-cells than in control cells. On the contrary, the ar weight (14,000 number of viable bacteria inside chemotactic Activity of these factor-treated leukocytes as well as the number (8, 5, 6) . viable in the total inoculum was less at each to enhance bac-time point than with control leukocytes ( cluded that the predominant action of these factors was to stimulate neutrophil intracellular bactericidal mechanisms.
DISCUSSION
The chemotactic factors may have stimulated oxygen-dependent or oxygen-independent bactericidal pathways. The requirements for oxygen-dependent bactericidal pathways was explored by using sodium azide-treated leukocytes, and leukocytes from a patient with CGD. Sodium azide is known to inhibit bacterial killing, probably by inhibiting myeloperoxidase (15) and perhaps other oxygen-dependent pathways. CGD neutrophils are defective in killing catalase-positive bacteria because of a primary defect in oxygen-dependent bactericidal pathways. In contrast, CGD neutrophils kill catalase-negative bacteria such as S. faecalis normally. C5a and FMP did not enhance the killing of S. aureus by azide-treated normal leukocytes or by CGD leukocytes (Fig. 6) . Furthermore, these agents did not enhance the killing of S. faecalis by CGD leukocytes (not shown), although they did enhance killing by normal neutrophils (see above). These findings suggest that chemotactic factors can enhance bacterial killing primarily by stimulating oxygen-dependent bactericidal pathways.
Further support for this hypothesis is gained from the finding that chemoattractants stimulate the HMPS activity of resting and phagocytosing neutrophils (Fig. 5) as was reported previously (4). Furthermore, C5a enhances superoxide production (11) and FMP (10-' M) and FMLP (10-8 M) stimulate neutrophil chemiluminescence (2, 12) , which was likely due to superoxide generation (12) . All of these reactions are associated with neutrophil killing ofbacteria.
Our finding that chemotactic substances enhance the bactericidal capacity of neutrophils may be an important link to understanding the interaction of biologically active molecules with effector cells in host defense.
